Abviax's Obefazimod shows strong potential in ulcerative colitis treatment. Upcoming phase 3 trial data in Q3 2025 is a key ...

“This funding gives us the ability to grow on our terms and grow faster,” said ITPartners founder and CEO Kevin Damghani. “Positively impacting people is at the heart of what we do, and this lets us ...

Announcing the passing of a loved one in local news media is a long standing tradition and we are proud of the trust placed ...

Danone U.S. is voluntarily recalling YoCrunch® products sold at retail stores nationwide due to the potential presence of ...